Your session is about to expire
← Back to Search
Gamification for Hospital Mobility Improvement (Level Up Trial)
N/A
Waitlist Available
Led By Ryan Greysen, MD, MHS, MA
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have an AMPAC (mobility scale) score of greater than or equal to 21 or a Braden mobility sub-scale score of 4.
Admitted to a medicine or cardiology floor in the hospital
Timeline
Screening 3 weeks
Treatment Varies
Follow Up average 35 days
Awards & highlights
Level Up Trial Summary
This trial will use wearable devices and 2-way texting to monitor patients' physical activity during hospitalization, with the goal of improving patient outcomes.
Who is the study for?
This trial is for hospital patients aged 50 or older with conditions like diabetes, heart disease, or obesity. They must be able to consent, have daily access to a smartphone (or use one provided), and not be in another activity study. Their mobility scores should indicate they can safely do physical activities.Check my eligibility
What is being tested?
The study tests if adding game-like elements (gamification) to monitoring devices increases patient movement in the hospital. It compares regular guidance with enhanced gamified feedback using wearables and texting, then tracks post-discharge health care use and function.See study design
What are the potential side effects?
Since this trial involves non-invasive interventions like wearable technology and text messaging rather than medications, side effects are minimal but may include discomfort from wearing the device or potential privacy concerns.
Level Up Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can move around well enough on my own.
Select...
I am currently admitted to a hospital's medicine or cardiology department.
Select...
I am 50 years old or older.
Level Up Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ average 35 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~average 35 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in mean daily step count during hospitalization
Secondary outcome measures
30-day acute care utilization
Change in activities of daily living
Change in difficulty with walking
+4 moreLevel Up Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Gamification InterventionExperimental Treatment1 Intervention
Participants will be recruited during an inpatient stay and given a Fitbit watch that will transmit data to the Way to Health study platform. Intervention patients will receive daily text messages to help them set goals, receive feedback and support on their progress towards daily goals, and receive points for daily goals achieved. Data will continue to be collected for 30 days after discharge.
Group II: ControlActive Control1 Intervention
Participants will be recruited during an inpatient stay and given a Fitbit watch that will transmit data to the Way to Health study platform. Control participants' steps will be passively monitored. Data will continue to be collected for 30 days after discharge.
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,009 Previous Clinical Trials
42,894,503 Total Patients Enrolled
5 Trials studying Coronary Artery Disease
270 Patients Enrolled for Coronary Artery Disease
Ryan Greysen, MD, MHS, MAPrincipal InvestigatorUniversity of Pennsylvania
4 Previous Clinical Trials
807 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can move around well enough on my own.I am currently admitted to a hospital's medicine or cardiology department.I don't use a smartphone daily and am not willing to use one provided for the study.I may need help with moving around due to my low mobility scores.I am 50 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Gamification Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Coronary Artery Disease Patient Testimony for trial: Trial Name: NCT04300764 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still openings available for this research endeavor?
"Clinicaltrials.gov reveals that this particular trial, posted on January 1st 2024 and last edited on September 3rd 2022, is not currently accepting participants. Thankfully, there are over 4000 other trials actively recruiting at present."
Answered by AI
Who else is applying?
What state do they live in?
Pennsylvania
What site did they apply to?
University of Pennsylvania
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
I’ve tried many diets and always fail hopefully I will be able to lose weight with your program.
PatientReceived 1 prior treatment
Recent research and studies
Share this study with friends
Copy Link
Messenger